Neurotoxicity of halogenated phenylacetylureas is linked to abnormal onset of rapid axonal transport

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

A structure-activity study was performed to investigate the mechanism of neurotoxicity induced in rats by treatment with p-bromophenylacetylurea (BPAU). Phenylacetylurea and 7 derivatives were tested for their ability to induce hindlimb weakness after twice weekly administration in doses of 200 mg/kg, up to a cumulative maximum of 2000 mg/kg. In this test, BPAU and its chloro-analog were about equipotent, but none of the other analogs displayed any evidence of neurotoxicity. Since BPAU toxicity was believed to involve abnormalities in rapid axonal transport, selected analogs were examined in a transport experiment. None of the compounds led to alterations in the maximal rate of rapid anterograde transport, as measured after intraspinal injections of [35S]methionine in rats treated with 400 mg/kg of toxicant, 7 days earlier. However, both BPAU and its chloro- analog caused marked shortening of the delay between isotope injection and transport onset, an effect not seen with either of the two non-neurotoxic analogs tested. It is hypothesized that the accelerated transport onset is a key step in development of the neuropathy, possibly causing organelle abnormalities that interfere with turnaround and recirculation of transported particles.

Original languageEnglish (US)
Pages (from-to)136-142
Number of pages7
JournalBrain Research
Volume385
Issue number1
DOIs
StatePublished - Oct 15 1986

Fingerprint

Axonal Transport
Spinal Injections
Hindlimb
Isotopes
Methionine
Organelles
Injections
Therapeutics
4-bromophenylacetylurea

Keywords

  • Experimental neuropathy
  • Motor neurons
  • p-Bromophenylacetylurea
  • Peripheral neurotoxicology
  • Rapid axonal transport

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Neurotoxicity of halogenated phenylacetylureas is linked to abnormal onset of rapid axonal transport. / Nagata, Hiroshi; Brimijoin, William Stephen.

In: Brain Research, Vol. 385, No. 1, 15.10.1986, p. 136-142.

Research output: Contribution to journalArticle

@article{1dc95b075bbf461d84f0f30b73c20e5f,
title = "Neurotoxicity of halogenated phenylacetylureas is linked to abnormal onset of rapid axonal transport",
abstract = "A structure-activity study was performed to investigate the mechanism of neurotoxicity induced in rats by treatment with p-bromophenylacetylurea (BPAU). Phenylacetylurea and 7 derivatives were tested for their ability to induce hindlimb weakness after twice weekly administration in doses of 200 mg/kg, up to a cumulative maximum of 2000 mg/kg. In this test, BPAU and its chloro-analog were about equipotent, but none of the other analogs displayed any evidence of neurotoxicity. Since BPAU toxicity was believed to involve abnormalities in rapid axonal transport, selected analogs were examined in a transport experiment. None of the compounds led to alterations in the maximal rate of rapid anterograde transport, as measured after intraspinal injections of [35S]methionine in rats treated with 400 mg/kg of toxicant, 7 days earlier. However, both BPAU and its chloro- analog caused marked shortening of the delay between isotope injection and transport onset, an effect not seen with either of the two non-neurotoxic analogs tested. It is hypothesized that the accelerated transport onset is a key step in development of the neuropathy, possibly causing organelle abnormalities that interfere with turnaround and recirculation of transported particles.",
keywords = "Experimental neuropathy, Motor neurons, p-Bromophenylacetylurea, Peripheral neurotoxicology, Rapid axonal transport",
author = "Hiroshi Nagata and Brimijoin, {William Stephen}",
year = "1986",
month = "10",
day = "15",
doi = "10.1016/0006-8993(86)91554-4",
language = "English (US)",
volume = "385",
pages = "136--142",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Neurotoxicity of halogenated phenylacetylureas is linked to abnormal onset of rapid axonal transport

AU - Nagata, Hiroshi

AU - Brimijoin, William Stephen

PY - 1986/10/15

Y1 - 1986/10/15

N2 - A structure-activity study was performed to investigate the mechanism of neurotoxicity induced in rats by treatment with p-bromophenylacetylurea (BPAU). Phenylacetylurea and 7 derivatives were tested for their ability to induce hindlimb weakness after twice weekly administration in doses of 200 mg/kg, up to a cumulative maximum of 2000 mg/kg. In this test, BPAU and its chloro-analog were about equipotent, but none of the other analogs displayed any evidence of neurotoxicity. Since BPAU toxicity was believed to involve abnormalities in rapid axonal transport, selected analogs were examined in a transport experiment. None of the compounds led to alterations in the maximal rate of rapid anterograde transport, as measured after intraspinal injections of [35S]methionine in rats treated with 400 mg/kg of toxicant, 7 days earlier. However, both BPAU and its chloro- analog caused marked shortening of the delay between isotope injection and transport onset, an effect not seen with either of the two non-neurotoxic analogs tested. It is hypothesized that the accelerated transport onset is a key step in development of the neuropathy, possibly causing organelle abnormalities that interfere with turnaround and recirculation of transported particles.

AB - A structure-activity study was performed to investigate the mechanism of neurotoxicity induced in rats by treatment with p-bromophenylacetylurea (BPAU). Phenylacetylurea and 7 derivatives were tested for their ability to induce hindlimb weakness after twice weekly administration in doses of 200 mg/kg, up to a cumulative maximum of 2000 mg/kg. In this test, BPAU and its chloro-analog were about equipotent, but none of the other analogs displayed any evidence of neurotoxicity. Since BPAU toxicity was believed to involve abnormalities in rapid axonal transport, selected analogs were examined in a transport experiment. None of the compounds led to alterations in the maximal rate of rapid anterograde transport, as measured after intraspinal injections of [35S]methionine in rats treated with 400 mg/kg of toxicant, 7 days earlier. However, both BPAU and its chloro- analog caused marked shortening of the delay between isotope injection and transport onset, an effect not seen with either of the two non-neurotoxic analogs tested. It is hypothesized that the accelerated transport onset is a key step in development of the neuropathy, possibly causing organelle abnormalities that interfere with turnaround and recirculation of transported particles.

KW - Experimental neuropathy

KW - Motor neurons

KW - p-Bromophenylacetylurea

KW - Peripheral neurotoxicology

KW - Rapid axonal transport

UR - http://www.scopus.com/inward/record.url?scp=0022484013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022484013&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(86)91554-4

DO - 10.1016/0006-8993(86)91554-4

M3 - Article

C2 - 2429734

AN - SCOPUS:0022484013

VL - 385

SP - 136

EP - 142

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -